Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells

MLA

Muneyuki, Masuda, et al. “Epigallocatechin-3-Gallate Inhibits Activation of HER-2/Neu and Downstream Signaling Pathways in Human Head and Neck and Breast Carcinoma Cells.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 9, no. 9, Sept. 2003. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........537a1a9aaeb61de318e5016aff9ee7c2&authtype=sso&custid=ns315887.

APA

Muneyuki, M., Masumi, S., Jin T E, L., & I Bernard, W. (2003). Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 9(9).

Chicago

Muneyuki, Masuda, Suzui Masumi, Lim Jin T E, and Weinstein I Bernard. 2003. “Epigallocatechin-3-Gallate Inhibits Activation of HER-2/Neu and Downstream Signaling Pathways in Human Head and Neck and Breast Carcinoma Cells.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 9 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........537a1a9aaeb61de318e5016aff9ee7c2&authtype=sso&custid=ns315887.